Navigation Links
Oxygen Dial Flowmeters - Ohmeda

ProductsOxygen Dial Flowmeters - Ohmeda
Company Amvex Corporation
Item Oxygen Dial Flowmeters - Ohmeda
Features 
  • Available in Oxygen and Air
  • Available in 25, 15, 8 and 4 LPM
  • Comes standard with a 1/8" FNPT connection but will be custom configured upon request
  • Available with a variety of adapters and accessories
  • Body is color coded to specific gas
  • Available in USA and ISO Colors
  • MRI options available
  • Comes with a 5 year warranty
  • Description Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO2. They are all available in a variety of calibrations to best suit your application. With color coded labels and dials specific to the gas in use, the Amvex Flowmeter is a user friendly device.
    Info Amvex Corporation
    Customer Service: (866) 462-6839
    Web site: http://amvex.com/

    Related medicine products :

    1. LICOX Brain Tissue Oxygen Monitoring System
    2. PULSOX-2 Oxygen Saturation Monitor
    3. LOTUS™ Electronic Oxygen Conserver (with alarm)
    4. OXYMATIC® 401 Electronic Oxygen Conserver
    5. LOTUS™ Electronic Oxygen Conserver (without alarm)
    6. OXYMATIC® 401A Electronic Oxygen Conserver
    7. OXYMATIC® 411A Electronic Oxygen Conserver
    8. OXYMATIC® 411 Electronic Oxygen Conserver
    9. OXYMATIC® 411AF Electronic Oxygen Conserver
    10. SEQUOIA OXYMATIC® 302 Electronic Oxygen Conserver
    11. SEQUOIA OXYMATIC® 312 Electronic Oxygen Conserver
    300 L, Bulk Recommended for 250 and 300 L pipettes....
    ... PerkinElmer manufactures Robotic Certified Tips for ... dispensing systems. Manufactured with the highest quality, ... to provide unparalleled accuracy in high throughput ... with a volume range from 0.5 L ...
    MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples, and genomic DNA....
    This extra long 180 ul pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
    Medicine Products:
    (Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
    (Date:8/22/2014)... Aug. 22, 2014 (HealthDay News) -- College can be a ... of things they can do to make the most of ... time to adjust, explore, meet new people and learn to ... of student wellness and assessment at St. John,s University in ... "Not all learning takes place in the classroom. College is ...
    (Date:8/22/2014)... A new, online conference is coming August 25th-29th, 2014 ... and open to everyone. Over 20 top experts will ... on how to stop emotional eating, start eating healthier and ... is not a diet. The concept is about how to ... this, don't eat that" approach. , You can sign up ...
    (Date:8/22/2014)... surgery for facial pain caused by trigeminal neuralgia, the ... a study in the September issue of ... of Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , Percutaneous stereotaxic rhizotomy ... than other types of surgical treatments for trigeminal neuralgia, ...
    (Date:8/22/2014)... (PRWEB) August 22, 2014 Ticket Down ... tickets in Kalamazoo, New Orleans, Albuquerque and Rapid City. ... the “Long Island Medium,” Theresa Caputo, allows just that. Caputo ... She is part of a close knit family who began ... with a spiritual healer, realized she had a chance to ...
    Breaking Medicine News(10 mins):Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:College Prep 101 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2
    ... the development of vascular diseases may also contribute to ... access in dialysis patients, according to a study appearing ... the American Society of Nephrology (JASN). "Our ... may contribute to the relatively poor outcomes regarding the ...
    ... HealthDay Reporter , WEDNESDAY, Dec. 22 (HealthDay News) -- ... as the "stroke belt" eat twice as much fried fish ... according to a new study looking at regional and ethnic ... The stroke belt, with more deaths from stroke than ...
    ... , WEDNESDAY, Dec. 22 (HealthDay News) -- A gene ... patients with glioblastoma brain cancer has been identified by ... as NFKBIA -- contributes to tumor development, promotes resistance ... of patients with glioblastoma, the most common and deadly ...
    ... , WEDNESDAY, Dec. 22 (HealthDay News) -- ... the hospital increases the risk of complications from infections ... new study. U.S. researchers looked at patients who ... surgery: 87,318 coronary artery bypass graft (CABG) procedures; 46,728 ...
    ... sex are you? Sex in mammals is genetically ... have one X and one Y chromosome. However, some individuals ... a condition known as XX male sex reversal. A team ... has now determined that overexpression of the Sox3 gene in ...
    ... On December 14-15, 2010, the U.S. Food and Drug Administration ... that may affect the regulation of dental amalgam. At the ... the FDA conduct further review of the material,s safety. ... Final Rule ( http://bit.ly/FDA2009FinalRule ) from the FDA that reclassified ...
    Cached Medicine News:Health News:Why does dialysis fail? 2Health News:Too Much Fried Fish Might Help Make South the 'Stroke Belt' 2Health News:Too Much Fried Fish Might Help Make South the 'Stroke Belt' 3Health News:Gene Mutation Found in One of Four Cases of Deadly Brain Cancers 2Health News:Timely Surgery Appears to Cut Infection Risk, Costs 2Health News:JCI table of contents: Dec. 22, 2010 2Health News:JCI table of contents: Dec. 22, 2010 3Health News:JCI table of contents: Dec. 22, 2010 4Health News:JCI table of contents: Dec. 22, 2010 5Health News:JCI table of contents: Dec. 22, 2010 6Health News:JCI table of contents: Dec. 22, 2010 7Health News:JCI table of contents: Dec. 22, 2010 8Health News:JCI table of contents: Dec. 22, 2010 9Health News:JCI table of contents: Dec. 22, 2010 10Health News:JCI table of contents: Dec. 22, 2010 11Health News:JCI table of contents: Dec. 22, 2010 12Health News:AADR testifies to the FDA advisory panel on dental amalgam 2
    (Date:8/22/2014)... -- Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... its President and Chief Executive Officer, will be stepping ... a member of the Board of Directors, effective as ... an interim basis by Michael T. Leatherman , ...
    (Date:8/21/2014)... GREENWICH, Conn. , Aug. 21, 2014 /PRNewswire/ ... West Lafayette, Indiana , has ... determination and characterization of small and large molecules, ... addition of the Bruker maXisPlus Q-TOF mass spectrometer. ... Jonathan Goldman , CEO, Aptuit, said, "The expanded ...
    (Date:8/21/2014)... DEERFIELD, Ill. , Aug. 21, 2014 /PRNewswire/ ... reports Baxter International Inc. today announced positive results ... BAX 855, an investigational, extended half-life recombinant factor ... ADVATE [Antihemophilic Factor (Recombinant)], which met its primary ... the prophylaxis arm compared to the on-demand arm. ...
    Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5